
    
      Baseline assessment will include a

        1. battery of eight cognitive tests

        2. Health related quality of life

        3. MRI head evaluating MR spectroscopy and diffusion tensor imaging

      Patients will then be given tolvaptan 15-30mg qd for 14 days after which the tests will be
      repeated. During the first 3 days of tolvaptan administration, patients will be admitted and
      serum sodium will be drawn every 8 hours. 24 hr urine collection will also be performed.

      Between the initiation and end of tolvaptan, patients will be seen at least every 3-5 days in
      between.

      Participation will be terminated in case patients get transplanted or develop overt HE in
      between.
    
  